Orlando, FL, July 26, 2005 - Hemoglobin A1c (HbA1c) reagents, calibrators and controls designed for use on Olympus AU400/400e®, AU640/640e®, AU2700® and AU5400® chemistry-immuno analyzers are now available.
The Olympus A1c assay is certified by the National Glycohemoglobin Standardization Program (NGSP), using the new protocol guidelines recommended for worldwide harmonization of A1c measurements.
Olympus A1c calibrator setpoints are referenced to International Federation of Clinical Chemistry (IFCC) reference standards. The Master Equation is employed for the conversion of patient results from IFCC to NGSP levels of % A1c in order to maintain values familiar to patients and clinicians, and which relate to the existing Diabetes Control and Complications Trial (DCCT) evidence-based outcome studies.
For additional information about Olympus HbA1c reagents, calibrators and controls, contact Carole Dauscher, Product Manager, Olympus Diagnostic Systems Group, at 1-800-223-0125 x5654 or email: firstname.lastname@example.org.
About Olympus Diagnostic Systems Group
Olympus Diagnostic Systems Group provides innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks and pharmaceutical labs. Olympus offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, comprehensive patient safety systems, blood bank analyzers and reagents. Olympus solutions save laboratories time, enhance patient safety, maximize productivity, and deliver fast, reliable results.
Olympus is a precision technology leader, designing and delivering innovative solutions in healthcare and consumer electronics worldwide.
Olympus works collaboratively with its customers and its parent company, Tokyo-based Olympus Corporation, to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:
- Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
- Advanced clinical and research microscopes;
- Lab automation systems, chemistry-immuno and blood bank analyzers and reagents; and
- Digital and film cameras, and digital voice recorders.
In the U. S. and Canada, Olympus serves healthcare, scientific and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers efficiently, reliably, safely, and easily achieve superior results. Olympus is the leader in gastrointestinal endoscopy and clinical and educational microscopes. The company's market-leading consumer electronics business spans North and South America. For more information, visit www.olympusamerica.com.